Ms. Leguizamon et al., ANTIBODIES INHIBITING TRYPANOSOMA-CRUZI TRANS-SIALIDASE ACTIVITY IN SERA FROM HUMAN INFECTIONS, The Journal of infectious diseases, 170(6), 1994, pp. 1570-1574
Trans-sialidase, an enzyme that transfers sialic acid among macromolec
ules, has been implicated in invasion of host cells by Trypanosoma cru
zi, the agent of Chagas' disease. Most antibodies produced in natural
and experimental infections are directed to the highly antigenic C-ter
minal domain (shed acute-phase antigen). These antibodies do not inhib
it the trans-sialidase activity, which is present in the N-terminal do
main of the molecule. Antibodies able to inhibit trans-sialidase in se
ra from human infections have been found. TIA (trans-sialidase inhibit
ion assay) was positive in sera from patients with acute and chronic i
nfections. Healthy and congenitally infected infants born to mothers w
ith Chagas' disease were also TIA-positive, but the antibody titers di
minished within months after birth or after treatment. Thus, antibodie
s neutralizing trans-sialidase are detectable in most forms of T. cruz
i human infections, and TIA may be useful in the diagnosis of Chagas'
disease.